Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

MDxHealth (MDXH) EBITDA Margin: 2019-2024

Historic EBITDA Margin for MDxHealth (MDXH) over the last 6 years, with Dec 2024 value amounting to 0.00%.

  • MDxHealth's EBITDA Margin changed 0.00% to 0.00% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.00%, marking a year-over-year change of 0.00%. This contributed to the annual value of 0.00% for FY2024, which is 0.00% changed from last year.
  • As of FY2024, MDxHealth's EBITDA Margin stood at 0.00%, which was up 45.53% from 0.00% recorded in FY2023.
  • MDxHealth's 5-year EBITDA Margin high stood at 0.00% for FY2024, and its period low was 0.00% during FY2021.
  • Moreover, its 3-year median value for EBITDA Margin was 0.00% (2023), whereas its average is 0.00%.
  • As far as peak fluctuations go, MDxHealth's EBITDA Margin soared by 36,630bps in 2020, and later decreased by 0bps in 2021.
  • Over the past 5 years, MDxHealth's EBITDA Margin (MRY) stood at 0.00% in 2020, then crashed by 481bps to 0.00% in 2021, then rose by 30bps to 0.00% in 2022, then skyrocketed by 68bps to 0.00% in 2023, then surged by 46bps to 0.00% in 2024.
  • Its EBITDA Margin stands at 0.00% for FY2024, versus 0.00% for FY2023 and 0.00% for FY2022.